Bind-X GmbH – Trademark Portfolio
Entity Type: 99
Bind-X GmbH holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 5 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include BIND-X.
Am Klopferspitz 19
82152 Planegg
Showing of trademarks Trademarks
Trademark Classifications
Bind-X GmbH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Bind-X GmbH have?
Bind-X GmbH has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does Bind-X GmbH file in?
Bind-X GmbH files trademarks across 5 Nice Classification classes. The most active classes are Class 19 (Building Materials), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 4 (Lubricants & Fuels), Class 5 (Pharmaceuticals). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are Bind-X GmbH's most well-known trademarks?
Bind-X GmbH's registered trademark portfolio includes well-known marks such as BIND-X. These are among 3 currently registered trademarks in the portfolio.
What is Bind-X GmbH's trademark registration success rate?
Bind-X GmbH has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.